Literature DB >> 30055863

LST1: A multifunctional gene encoded in the MHC class III region.

Ulrich H Weidle1, Ina Rohwedder2, Fabian Birzele3, Elisabeth H Weiss4, Christian Schiller5.   

Abstract

The LST1 gene is located in the MHC class III cluster between the MHC class I and II regions. While most genes in this cluster have been sufficiently characterised, a definitive function and expression pattern for LST1 still remains elusive. In the present review we describe its promotor, gene organisation, splice variants and expression in human tissues, cell lines and cancer. We focus on LST1 expression in inflammation and discuss known correlations with autoimmune diseases and cancer. Current data on LST1 polymorphisms and their known associations with pathologies are also discussed in detail. We summarize the potential functions that have been described for the full-length LST1 protein including its function as a transmembrane adaptor protein with inhibitory signal transduction and its role as a membrane scaffold facilitating the formation of tunnelling nanotubes. We also discuss further potential functions by compiling all known LST1-interacting proteins. Furthermore, we address knowledge gaps and conflictive issues regarding disease association, non-hematopoietic expression and the discrepancy between RNA and protein expression data.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Inflammation; MHC class III; Transmembrane adaptor protein; Tunneling nanotubes

Mesh:

Substances:

Year:  2018        PMID: 30055863     DOI: 10.1016/j.imbio.2018.07.018

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  1 in total

1.  Regulation of Inflammatory Response by Transmembrane Adaptor Protein LST1.

Authors:  Matej Fabisik; Jolana Tureckova; Nataliia Pavliuchenko; Jarmila Kralova; Jana Balounova; Kristina Vicikova; Tereza Skopcova; Frantisek Spoutil; Jana Pokorna; Pavla Angelisova; Bernard Malissen; Jan Prochazka; Radislav Sedlacek; Tomas Brdicka
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.